Cost-effectiveness of pharmacological and psychosocial interventions for schizophrenia.

ABSTRACT:

Background

Information on cost-effectiveness of interventions to treat schizophrenia can assist health policy decision making, particularly given the lack of health resources in developing countries like Thailand. This study aims to determine the optimal treatment package, including drug and non-drug interventions, for schizophrenia in Thailand.

Methods

A Markov model was used to evaluate the cost-effectiveness of typical antipsychotics, generic risperidone, olanzapine, clozapine and family interventions. Health outcomes were measured in disability adjusted life years. We evaluated intervention benefit by estimating a change in disease severity, taking into account potential side effects. Intervention costs included outpatient treatment costs, hospitalization costs as well a

SUBMITTER: Phanthunane P 

PROVIDER: S-EPMC3120770 | biostudies-literature | 2011 May

REPOSITORIES: biostudies-literature